Chengdu Huasun Technology Group Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chengdu Huasun Technology Group Co Ltd with three other
companies in this sector in CHINA :
Wuhan Hvsen Biotechnology Co Ltd
sales of 777.46 million Chinese Renmimbi [US$120.78 million]
of which 81%
was Veterinary chemical preparations),
Shanghai Kai Kai Industry Co Ltd
(761.82 million Chinese Renmimbi [US$118.35 million]
of which 94%
was Commerce), and
Zhejiang Cheng Yi Pharmaceutical Co Ltd
(758.13 million Chinese Renmimbi [US$117.78 million]
of which 100%
was Pharmaceutical Manufacturing Industry).
During the year ended December of 2020, sales at
Chengdu Huasun Technology Group Co Ltd were 759.31 million Chinese Renmimbi (US$117.96 million).
a very small
increase of 1.9%
versus 2019, when the company's sales were 745.34 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Chengdu Huasun Technology Group Co Ltd
(and since 2015, sales have increased a total of 64%).
Sales of Steel Structure Design and Manufacturing saw an increase
that was more than double the company's growth rate: sales were up
97.7% in 2020, from
94.70 million Chinese Renmimbi to 187.24 million Chinese Renmimbi.
Not all segments of Chengdu Huasun Technology Group Co Ltd experienced an increase in sales in 2020:
sales of Medicine Manufacturing fell 12.1% to 572.07 million Chinese Renmimbi.